1-2 of 2
Antoine N. Saliba
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm

Open Access
Chung Hoow Kok, Aref Al-Kali, Daniel Thomas, Rong He, Monika M. Kutyna, Hassan Alkhateeb, Kelly Lim, Antoine N. Saliba, Carla Toop, Aasiya Matin, Hamish Scott, Naseema Gangat, Anna Brown, Abhishek Mangaonkar, Christopher N. Hahn, Kebede Begna, Kevin Hung, Patricia Greipp, William J. Hogan, Mrinal Patnaik, Mithun Shah, Devendra K. Hiwase
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3814–3818.
https://doi.org/10.1182/bloodadvances.2025016374
Published: 2025
Includes: Supplemental data
Journal Articles

Pevonedistat with azacitidine in older patients with TP53 -mutated AML: a phase 2 study with laboratory correlates

Free
Clinical Trials & Observations
Antoine N. Saliba, Scott H. Kaufmann, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock, Michael Deininger, William Blum, Gary J. Schiller, Rebecca L. Olin, Mark R. Litzow, Tara L. Lin, Brian J. Ball, Michael M. Boyiadzis, Elie Traer, Olatoyosi Odenike, Martha L. Arellano, Alison Walker, Vu H. Duong, Tibor Kovacsovics, Robert H. Collins, Abigail B. Shoben, Nyla A. Heerema, Matthew C. Foster, Kevin L. Peterson, Paula A. Schneider, Molly Martycz, Theophilus J. Gana, Leonard Rosenberg, Sonja Marcus, Ashley O. Yocum, Timothy Chen, Mona Stefanos, Alice S. Mims, Uma Borate, Amy Burd, Brian J. Druker, Ross L. Levine, John C. Byrd, James M. Foran
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2360–2363.
https://doi.org/10.1182/bloodadvances.2022008625
Published: 2023
Includes: Supplemental data